STAT

APRIL 25, 2025

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. Compounding pharmacies are legally allowed to make versions of branded treatments if the drugs are deemed to be in shortage by the FDA.

Compounding 184

Compounding Compounding Pharmacies Diabetes 184

STAT

DECEMBER 4, 2024

Also, compounding pharmacies fire back at Novo Nordisk for its assertion that GLP-1 drugs are too difficult to compound. Lots today on GLP-1s: First we see tirzepatide outperforming semaglutide in a head-to-head study in obesity. Also, a Michael Gilman company pivots and more. Read the rest…

Compounding Pharmacies 240

Compounding Pharmacies Compounding Drug Pricing Drug Development 240

STAT

JANUARY 6, 2025

Food and Drug Administration seeking to block compounding pharmacies in the U.S. We hope you have a meaningful and manageable day. Best of luck, and do keep in touch. … Novo Nordisk filed another citizen’s petition with the U.S. from making versions of one of its GLP-1 agonist drugs , Pharmaphorum notes.

Compounding 259

Compounding Compounding Pharmacies Diabetes Communication 259

STAT

OCTOBER 22, 2024

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. The FDA still has to make a decision on whether to officially place semaglutide on the lists.

Compounding 358

Compounding Compounding Pharmacies Documentation Diabetes 358

STAT

APRIL 29, 2025

Good morning, we’ve got a bunch of news this morning about GLP-1 drugs,  compounding, and biotechs’ interactions with the FDA. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Let’s get into it. Read the rest…

Compounding 172

Compounding Drug Pricing Drug Development 172

STAT

OCTOBER 30, 2024

Over the past two years, patients seeking treatment have been turning to compounding pharmacies, which make cheaper copies of branded treatments and are legally allowed to do so only when the branded treatments are listed on the FDA’s shortage list.

Compounding Pharmacies 324

Compounding Pharmacies Compounding Diabetes 324

STAT

OCTOBER 11, 2024

The move was a clear warning to compounders that they can no longer make copycat versions of the drugs — a process that is only permitted when the medications are on an official agency shortage list. Read the rest…

Compounding 353

Compounding Diabetes 353

STAT

MARCH 7, 2025

Today, we unpack Marty Makary’s Senate  confirmation hearing, see a new ruling against GLP-1 compounders, examine the effects of the NIH patent freeze, and explore the tumultuous biotech job market.   Sign up  to get our biotech newsletter in your inbox. Read the rest…

Compounding 209

Compounding Drug Pricing Drug Development 209

STAT

SEPTEMBER 20, 2023

As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding 340

Compounding Compounding Pharmacies Diabetes 340

STAT

OCTOBER 8, 2024

A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list.

Compounding 334

Compounding Compounding Pharmacies Diabetes Drug Pricing 334

STAT

MAY 20, 2025

… Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk’s Wegovy as the U.S. Noom offers its compounded semaglutide at a starting price of $149 for the first month. milligram vial of Wegovy or Zepbound costs $349, according to the Novo and Lilly websites.

Compounding 145

Compounding Diabetes 145

STAT

OCTOBER 6, 2023

judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines, which are widely prescribed for weight loss and have become franchise products for the drug company. The drug maker argued the compounders were selling versions of its medicines that were never approved by the U.S.

Compounding 282

Compounding Compounding Pharmacies 282

STAT

FEBRUARY 25, 2025

… Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the company seeks to draw patients away from cheap, compounded copies of weight loss medications , STAT reports. Pharmacy compounders sued the U.S. Continue to STAT+ to read the full story…

Compounding 164

Compounding Compounding Pharmacies Diabetes Communication 164

STAT

NOVEMBER 4, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online meetings, phone calls, and deadlines has returned. But you knew this would happen, yes? The world, such as it is, continues to spin.

Compounding 237

Compounding Pharmaceutical Companies Pharmaceutical Companies 237

STAT

MAY 15, 2023

At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary guidance allowing traditional compounding pharmacies, within tight regulatory guardrails, to prepare 13 Covid drugs from pure ingredients to meet hospitals’ urgent need.

Compounding Pharmacies 246

Compounding Pharmacies Compounding Hospitals 246

STAT

NOVEMBER 30, 2023

Novo Nordisk filed lawsuits against two compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide, the active ingredient in Wegovy and Ozempic (see here and here ). Testing of compounded drugs from these pharmacies revealed unknown impurities up to 33%, the company claims.

Compounding 261

Compounding Compounding Pharmacies Chemotherapy 261

STAT

OCTOBER 23, 2024

Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make , STAT reports. Novo has repeatedly argued that compounded products are risky, stressing that they are not approved by the FDA.

Compounding 243

Compounding Compounding Pharmacies Documentation Biosimilars 243

STAT

JULY 26, 2023

One of the largest compound pharmacy operations in the U.S. Yet the compounder failed to investigate the causes or take adequate corrective or preventive actions to mitigate the risk of formation. The Food and Drug Administration found several issues that raised the possibility of contamination during an inspection of an Allentown, Pa.,

Compounding 246

Compounding Hospitals Compounding Pharmacies 246

STAT

OCTOBER 12, 2022

Food and Drug Administration and a trade group that represents large compound pharmacies have resolved a long-running dispute over the use of bulk ingredients, clearing the way for some compounded medicines to become available more quickly. Continue to STAT+ to read the full story…

Compounding Pharmacies 241

Compounding Pharmacies Compounding 241

STAT

SEPTEMBER 19, 2024

Hims & Hers Health plans to sell compounded versions of Novo Nordisk’s popular weight loss drug Wegovy to patients in certain professions for $99 a month , Reuters says. Compounded GLP-1 injections are fulfilled and shipped from Hims & Hers affiliated pharmacies and are regulated by the FDA.

Compounding 230

Compounding Compounding Pharmacies Packaging 230

STAT

AUGUST 10, 2023

In late May, the Food and Drug Administration said it received a “few” adverse event reports concerning compounded versions of the injectable medicines, which both contain the same active ingredient, known as semaglutide.

Compounding 246

Compounding Diabetes 246

STAT

MAY 6, 2025

By 2024, one-third of their new compounds were coming from Chinese biotechnology firms. As in many other industries, it’s so much cheaper to synthesize new compounds inside Chinese biotechnology firms once a novel biological target has been discovered in American laboratories. Five years ago, U.S. Why are U.S.

Compounding 321

Compounding Pharmaceutical Companies Pharmaceutical Companies 321

STAT

JANUARY 7, 2025

 The plants’ inability to remove compounds known as organofluorines from wastewater before they enter drinking water supplies becomes even more pronounced during droughts and could affect up to 23 million people.    Most of the compounds came from commonly prescribed medications including antidepressants and statins.

Compounding 246

Compounding Documentation 246

STAT

SEPTEMBER 13, 2024

I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her chest pain, which, in the context of her family history of early-onset heart attacks and her morbid obesity, understandably concerned her primary care doctor.

Compounding 309

Compounding 309

STAT

MARCH 5, 2025

Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs.

Compounding Pharmacies 257

Compounding Pharmacies Compounding 257

STAT

APRIL 25, 2025

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We expect to promenade with the official mascots and catch up on our reading, but are, otherwise, open to suggestion.

Compounding 183

Compounding 183

STAT

JANUARY 22, 2025

” Experts told STAT there’s been a surge of interest for these compounds from biotech and pharma in the last few months, spurred on most by the presentation of promising clinical data from Summit Therapeutics.

Immunity 354

Immunity Immunization Compounding Drug Development 354

PharmaTech

JULY 8, 2025

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.

Compounding 64

Compounding Dosage 64

STAT

DECEMBER 20, 2024

The agency will give compounders a grace period of 60 to 90 days before enforcing rules that would put a halt to their work, in an effort to avoid disruption for patients. That should have prohibited compounders from continuing to make copies, because they can do so only when a treatment is on the shortage list.

Compounding 226

Compounding Diabetes 226

STAT

FEBRUARY 7, 2025

wrote that they worry that the Hims ad, which will be seen by millions of people during the big game on Sunday, “risks misleading patients by omitting any safety or side effect information” about the compounded weight loss drugs that it promotes. Dick Durbin (D-Ill.) and Roger Marshall (R-Kan.)

Compounding 203

Compounding 203

STAT

SEPTEMBER 20, 2023

… As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding 237

Compounding Compounding Pharmacies Diabetes 237

STAT

JULY 1, 2025

  In a Phase 2b clinical trial, Beckley’s compound, BPL-003 — an intranasal formulation of mebufotenin, a short-acting compound related to the psychedelic DMT — led to a reduction of 12.1 Kennedy, Jr. 

Compounding 275

Compounding 275

STAT

DECEMBER 4, 2024

  A trade group for compounding pharmacies slammed an attempt by Novo Nordisk to convince the U.S. Food and Drug Administration that semaglutide — the key ingredient in its diabetes and obesity drugs — should be added to a list of medicines that are too difficult to compound.

Compounding 171

Compounding Compounding Pharmacies Diabetes Documentation 171

STAT

AUGUST 29, 2024

Hims & Hers, one of the largest publicly traded telehealth companies in the country, has supercharged its business in the last several months by offering compounded versions of the patented weight loss drugs known as GLP-1s. That has regularly been the case lately with GLP-1 drugs marketed by Novo Nordisk and Eli Lilly.  

Compounding 349

Compounding 349

STAT

OCTOBER 11, 2024

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs. 

Compounding Pharmacies 334

Compounding Pharmacies Compounding Diabetes 334

STAT

SEPTEMBER 21, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Compounding 293

Compounding 293

STAT

MARCH 20, 2025

Food and Drug Administration wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies that have fueled widespread use of the knockoffs have other plans , The Wall Street Journal writes. And some pharmacies making the GLP-1 drug copycats will continue.

Compounding Pharmacies 224

Compounding Pharmacies Compounding Dosage 224